Showing results (301-310 of 784) with videos related to

Sort By:
Pageof 79
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|November 16, 2021
Structure-function analysis for macular surgery in patients with coexisting glaucomaSarah N Yu, Donald C Hood, Dana M Blumberg, et al.
Nature|November 3, 1986
Loss of mouse fibroblast cell response to phorbol esters restored by microinjected protein kinase CG Pasti, J C Lacal, B S Warren, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 3, 2016
Contacts of retreatment tuberculosis cases with a prior poor treatment outcome are at increased risk of latent tuberculosis infectionDavit Baliashvili, Matthew J Magee, Russell R Kempker, et al.
The Journal of Infectious Diseases|April 30, 2003
Human herpesvirus 6 genome and antigen in acute multiple sclerosis lesionsAndrew D Goodman, David J Mock, James M Powers, et al.
Emerging Infectious Diseases|May 21, 2015
Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant TuberculosisRussell R Kempker, Maia Kipiani, Veriko Mirtskhulava, et al.
Biochemical Pharmacology|May 8, 1992
Binding of [3H]bryostatin 4 to protein kinase CN E Lewin, M L Dell'Aquila, G R Pettit, et al.
The Annals of Pharmacotherapy|October 5, 2006
Polymyxin B and doxycycline use in patients with multidrug-resistant Acinetobacter baumannii infections in the intensive care unitKatherine P Holloway, Nadine G Rouphael, Jane B Wells, et al.
Cancer Research|April 16, 1998
Differential selectivity of ligands for the C1a and C1b phorbol ester binding domains of protein kinase Cdelta: possible correlation with tumor-promoting activityK Bögi, P S Lorenzo, Z Szállási, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
Synthesis of 7,8-disubstituted benzolactam-V8 and its binding to protein kinase CD Ma, T Zhang, G Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 22, 2007
Antinociceptive pharmacology of N-(4-chlorobenzyl)-N'-(4-hydroxy-3-iodo-5-methoxybenzyl) thiourea, a high-affinity competitive antagonist of the transient receptor potential vanilloid 1 receptorLei Tang, Yan Chen, Zili Chen, et al.
Pageof 79